Editorial Board About Us

Nomograms

All articles from this key word are listed below.

Volume 5, Number 2 Meeting Reviews

Advances in Prostate Cancer Treatment

Highlights from the 2nd International Prostate Cancer Congress, St. Thomas, U.S. Virgin Islands

Matthew B Gretzer Alan W Partin

Prostate-specific antigen Nomograms Radiotherapy Hormone-refractory prostate cancer Radioimmunoscintigraphy Androgen blockade

Volume 6, Number 2 Review Articles

Beyond Prostate-Specific Antigen: New Serologic Biomarkers for Improved Diagnosis and Management of Prostate Cancer

Diagnostic Update

Kevin M Slawin Shahrokh F Shariat Eduardo I Canto Michael W Kattan

Prostate cancer Prostate-specific antigen Biomarkers Nomograms Insulin-like growth factor Interleukin-6 Transforming growth factor ß1 Urokinase

Volume 6, Supplement 4 Supplement

Minimally Invasive Therapy for Prostate Cancer: Use of Nomograms to Counsel Patients About the Choice and Probable Outcome of Therapy

Kevin M Slawin Christopher J DiBlasio Michael W Kattan

Robotic surgery Nomograms Localized prostate cancer Cryotherapy Brachytherapy Minimally invasive therapy Minimally invasivesurgery Prediction tools

Volume 8, Number 3 Review Articles

The Importance of Pelvic Lymph Node Dissection in Men With Clinically Localized Prostate Cancer

Diagnostic Review

Mohamad E Allaf Alan W Partin H Ballentine Carter

Despite advances in noninvasive staging, pelvic lymph node dissection (PLND) remains the most accurate means of detecting lymph node metastases in men with clinically localized prostate cancer. Nomograms exist that can identify patients at low risk for lymphatic metastases according to preoperative information. In general, it seems reasonable to omit PLND in men with a biopsy Gleason sum of 6 or less and a prostate-specific antigen level of 10 ng/mL or less. Ultimately, however, this decision should be made according to physician and patient preference, considering the low contemporary morbidity associated with PLND. When PLND is performed, studies suggest that an extended dissection maximizes the detection rate of nodal involvement. Retrospective data indicate that an extended dissection might play a therapeutic role in a subset of patients with a limited lymph node burden. However, this might be an artifact of stage migration, and prospective studies are needed to evaluate this further. [Rev Urol. 2006;8(3):112-119]

Prostate cancer Nomograms Radioimmunoscintigraphy Lymphadenectomy Clinical staging Magnetic resonanceimaging Algorithms

Volume 10, Number 4 Review Articles

Using Biopsy to Detect Prostate Cancer

Diagnostic Review

Shahrokh F Shariat Claus G Roehrborn

Transrectal ultrasound-guided systemic biopsy is the recommended method in most cases with suspicion of prostate cancer. Transrectal periprostatic injection with a local anesthetic may be offered as effective analgesia; periprostatic nerve block with 1% or 2% lidocaine is the recommended form of pain control. On initial biopsy, a minimum of 10 systemic, laterally directed cores is recommended, with more cores in larger glands. Extended prostate biopsy schemes, which require cores weighted more laterally at the base (lateral horn) and medially to the apex, show better cancer detection rates without increasing adverse events. Transition zone biopsies are not recommended in the first set of biopsies, owing to low detection rates. One set of repeat biopsies is warranted in cases with persistent indication. Saturation biopsy (=20 cores) should be reserved for repeat biopsy in patients who have negative results on initial biopsy but who are still strongly suspected to have prostate cancer. [Rev Urol. 2008;10(4):262-280]

Prostate cancer Biopsy Prostate-specific antigen Transrectal ultrasound Nomograms Anesthesia

Volume 18, Number 1 Review Articles

Nephrolithometric Scoring Systems to Predict Outcomes of Percutaneous Nephrolithotomy

Management Update

Simone L Vernez Zhamshid Okhunov Piruz Motamedinia Vincent Bird Zeph Okeke Arthur Smith

Currently, there is no single agreement upon an ideal predictive model that characterizes the complexity of renal stones and predicts surgical outcomes following percutaneous nephrolithotomy (PCNL). New predictive tools have recently emerged to systematically and quantitatively assess kidney stone complexity to predict outcomes following PCNL: the Guy’s Stone Score, the CROES nomogram, S.T.O.N.E. nephrolithometry, and S-ReSC score. An ideal scoring system should include variables that both influence surgical planning and are predictive of postoperative outcomes. This review discusses the strengths, weaknesses, and commonalities of each of the above scoring systems. Additionally, we propose future directions for the development and analysis of surgical treatment for stone disease, namely, the importance of assessing radiation exposure and patient quality of life when counseling patients on treatment options. [Rev Urol. 2016;18(1):15-27 doi: 10.3909/riu0693] © 2016 MedReviews®, LLC

Percutaneous nephrolithotomy Urolithiasis Scoring system Nomograms